ClinicalTrialsFinder

Aggressive Fibromatosis Clinical Trials in Meldola, Forli-Cesena

1 recruitingMeldola, Forli-Cesena, Italy

Showing 1–1 of 1 trials

Recruiting
Phase 4

Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

Desmoid TumorAggressive Fibromatosis
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany50 enrolled21 locationsNCT07176689